BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 24579249)

  • 21. Multimodality management of malignant pleural mesothelioma.
    Sugarbaker DJ; Norberto JJ
    Chest; 1998 Jan; 113(1 Suppl):61S-65S. PubMed ID: 9438692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and treatment of malignant pleural mesothelioma.
    Rodríguez Panadero F
    Arch Bronconeumol; 2015 Apr; 51(4):177-84. PubMed ID: 25059587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.
    Kataoka Y; Yamamoto Y; Otsuki T; Shinomiya M; Terada T; Fukuma S; Yamazaki S; Hirabayashi M; Nakano T; Fukuhara S
    Jpn J Clin Oncol; 2015 Jun; 45(6):562-8. PubMed ID: 25838292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-institution experience of intensity-modulated radiotherapy for malignant pleural mesothelioma at University of Catania.
    Spatola C; Militello C; Tocco A; Salamone V; Luigi R; Migliore M; Marletta D; Cannizzaro A; Bevilacqua R; Milone P; Pergolizzi S; Privitera G
    Future Oncol; 2018 Mar; 14(6s):17-21. PubMed ID: 29400553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current surgical strategies for malignant pleural mesothelioma.
    Takuwa T; Hasegawa S
    Surg Today; 2016 Aug; 46(8):887-94. PubMed ID: 26590581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemithoracic radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma: Toxicity and outcomes at an Australian institution.
    Bece A; Tin MM; Martin D; Lin R; McLean J; McCaughan B
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):355-62. PubMed ID: 25753747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel induction therapies for pleural mesothelioma.
    Donahoe L; Cho J; de Perrot M
    Semin Thorac Cardiovasc Surg; 2014; 26(3):192-200. PubMed ID: 25527013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pleural mesothelioma: is the surgeon still there?
    Opitz I; Weder W
    Ann Oncol; 2018 Aug; 29(8):1710-1717. PubMed ID: 29905765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant Mesothelioma: Has Anything Changed?
    Kim RY; Sterman DH; Haas AR
    Semin Respir Crit Care Med; 2019 Jun; 40(3):347-360. PubMed ID: 31525810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experience in treating patients with malignant pleural mesothelioma].
    Uramoto H; Shimokawa H; Baba T; Shigematsu Y; Nagata Y; Ono K; Takenoyama M; Hanagiri T
    J UOEH; 2010 Sep; 32(3):257-64. PubMed ID: 20857819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Updates in Staging and Management of Malignant Pleural Mesothelioma.
    Wolf AS; Flores RM
    Surg Oncol Clin N Am; 2020 Oct; 29(4):603-612. PubMed ID: 32883461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
    Kircheva DY; Husain AN; Watson S; Kindler HL; Durkin A; Vigneswaran WT
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1642-7. PubMed ID: 26802143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant pleural mesothelioma.
    Kindler HL
    Curr Treat Options Oncol; 2000 Oct; 1(4):313-26. PubMed ID: 12057157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma.
    Soldera SV; Kavanagh J; Pintilie M; Leighl NB; de Perrot M; Cho J; Hope A; Feld R; Bradbury PA
    Oncologist; 2019 Jul; 24(7):e510-e517. PubMed ID: 30478189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
    Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma.
    Giroux Leprieur E; Hirata T; Mo M; Chen Z; Okamoto J; Clement G; Li H; Wislez M; Jablons DM; He B
    Lung Cancer; 2014 Sep; 85(3):465-71. PubMed ID: 25023662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgery as part of radical treatment for malignant pleural mesothelioma.
    Waller DA; Tenconi S
    Curr Opin Pulm Med; 2017 Jul; 23(4):334-338. PubMed ID: 28590338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Miliary mesothelioma: a new clinical and radiological presentation in mesothelioma patients with prolonged survival after trimodality therapy.
    Purek L; Laroumagne S; Dutau H; Maldonado F; Astoul P
    J Thorac Oncol; 2011 Oct; 6(10):1753-6. PubMed ID: 21918389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local and systemic therapies for malignant pleural mesothelioma.
    Gomez D; Tsao AS
    Curr Treat Options Oncol; 2014 Dec; 15(4):683-99. PubMed ID: 25266654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years.
    Friedberg JS; Simone CB; Culligan MJ; Barsky AR; Doucette A; McNulty S; Hahn SM; Alley E; Sterman DH; Glatstein E; Cengel KA
    Ann Thorac Surg; 2017 Mar; 103(3):912-919. PubMed ID: 27825687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.